NPPA and COVID-19: Meanwhile, a variety of currently used or investigational drugs such as statins, tyrosine kinase inhibitors, atrial natriuretic peptide, S1P1 agonists that exert endothelial protective or repair effects may be explored for their effects in COVID-19.